These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38880024)

  • 21. Berberine Derivatives with Different Pharmacological Activities via Structural Modifications.
    Xiao D; Liu Z; Zhang S; Zhou M; He F; Zou M; Peng J; Xie X; Liu Y; Peng D
    Mini Rev Med Chem; 2018; 18(17):1424-1441. PubMed ID: 28325147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action.
    Jiang H; Li J; Wang L; Wang S; Nie X; Chen Y; Fu Q; Jiang M; Fu C; He Y
    J Ethnopharmacol; 2020 Aug; 258():112913. PubMed ID: 32371143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Berberine: new perspectives for old remedies.
    Tillhon M; Guamán Ortiz LM; Lombardi P; Scovassi AI
    Biochem Pharmacol; 2012 Nov; 84(10):1260-7. PubMed ID: 22842630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine's effect on periodontal tissue degradation by matrix metalloproteinases: an in vitro and in vivo experiment.
    Tu HP; Fu MM; Kuo PJ; Chin YT; Chiang CY; Chung CL; Fu E
    Phytomedicine; 2013 Oct; 20(13):1203-10. PubMed ID: 23867651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.
    Tang J; Feng Y; Tsao S; Wang N; Curtain R; Wang Y
    J Ethnopharmacol; 2009 Oct; 126(1):5-17. PubMed ID: 19686830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory, antioxidant, and immunomodulatory effects of Berberis vulgaris and its constituent berberine, experimental and clinical, a review.
    Shakeri F; Kiani S; Rahimi G; Boskabady MH
    Phytother Res; 2024 Apr; 38(4):1882-1902. PubMed ID: 38358731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Berberine: A natural modulator of immune cells in multiple sclerosis.
    Yazdanpanah E; Dadfar S; Shadab A; Orooji N; Nemati M; Pazoki A; Esmaeili SA; Baharlou R; Haghmorad D
    Immun Inflamm Dis; 2024 Mar; 12(3):e1213. PubMed ID: 38477663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management.
    Shen P; Jiao Y; Miao L; Chen JH; Momtazi-Borojeni AA
    J Cell Mol Med; 2020 Nov; 24(21):12234-12245. PubMed ID: 32969153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research progress on the pharmacological effects of berberine targeting mitochondria.
    Fang X; Wu H; Wei J; Miao R; Zhang Y; Tian J
    Front Endocrinol (Lausanne); 2022; 13():982145. PubMed ID: 36034426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in shikonin for the treatment of immune-related diseases: Anti-inflammatory and immunomodulatory mechanisms.
    Guo Y; Zhou M; Mu Z; Guo J; Hou Y; Xu Y; Geng L
    Biomed Pharmacother; 2023 Sep; 165():115138. PubMed ID: 37454591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Proniosome Gel Formulation for CHIKV Infection.
    Altay Benetti A; Thwin MT; Suhaimi A; Liang RST; Ng LF; Lum FM; Benetti C
    Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Berberine and musculoskeletal disorders: The therapeutic potential and underlying molecular mechanisms.
    Wong SK; Chin KY; Ima-Nirwana S
    Phytomedicine; 2020 Jul; 73():152892. PubMed ID: 30902523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
    Ma X; Jiang Y; Wu A; Chen X; Pi R; Liu M; Liu Y
    PLoS One; 2010 Oct; 5(10):e13489. PubMed ID: 20976070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Berberine: A multifaceted agent for lung cancer treatment-from molecular insight to clinical applications.
    Xu X; He Y; Liu J
    Gene; 2025 Jan; 934():149021. PubMed ID: 39427827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches.
    Habtemariam S
    Biomedicines; 2020 Apr; 8(4):. PubMed ID: 32325761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberine as a promising natural compound for the treatment of periodontal disease: A focus on anti-inflammatory properties.
    Mohammadian Haftcheshmeh S; Momtazi-Borojeni AA
    J Cell Mol Med; 2021 Dec; 25(24):11333-11337. PubMed ID: 34719112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Berberine on the Prevention and Management of Cardiometabolic Disease: Clinical Applications and Mechanisms of Action.
    Cao RY; Zheng Y; Zhang Y; Jiang L; Li Q; Sun W; Gu W; Cao W; Zhou L; Zheng H; Yang J
    Am J Chin Med; 2021; 49(7):1645-1666. PubMed ID: 34488551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulating gut microbiota as an anti-diabetic mechanism of berberine.
    Han J; Lin H; Huang W
    Med Sci Monit; 2011 Jul; 17(7):RA164-7. PubMed ID: 21709646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the pharmacological mechanisms of berberine in the treatment of fibrosis.
    Liu X; Liang Q; Wang Y; Xiong S; Yue R
    Front Pharmacol; 2024; 15():1455058. PubMed ID: 39372209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine: A Traditional Natural Product With Novel Biological Activities.
    Hou Q; He WJ; Wu YS; Hao HJ; Xie XY; Fu XB
    Altern Ther Health Med; 2020 Jul; 26(S2):20-27. PubMed ID: 31634873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.